Pulmonary arterial hypertension in congenital cardiac disease--the need for refinement of the Evian-Venice classification

Cardiology in the Young
Mirjam E van Albada, Rolf Berger

Abstract

Pulmonary hypertension associated with congenital systemic-to-pulmonary shunts has been classified, in the Evian-Venice classification, as Pulmonary Arterial Hypertension, which includes a heterogeneous group of conditions. Emerging options for treatment of patients with pulmonary arterial hypertension are related to those with the idiopathic form of the disease, but may also improve quality of life and survival in patients with pulmonary arterial hypertension associated with congenital cardiac disease. Despite the evident similarities in pulmonary vascular disease, it is important also to recognise the differences between patients in whom pulmonary arterial hypertension is the consequence of systemic-to-pulmonary shunts as opposed to those with other conditions. Patients with pulmonary hypertension associated with congenital cardiac disease themselves constitute a heterogeneous population, in which generalisation may be hazardous. Specific considerations need to be given to the type of cardiac diagnosis, the prognosis and evolution of pulmonary vascular disease, and the circulatory physiology before embarking on new strategies for medical treatment in the individual patient. In this review, we highlight the features that requi...Continue Reading

References

Apr 1, 1989·Journal of the American College of Cardiology·L K HornbergerK J Chung
Aug 1, 1987·Annals of Internal Medicine·S RichS K Koerner
May 1, 1968·Circulation·R J Craig, A Selzer
Feb 1, 1996·The New England Journal of Medicine·R J BarstUNKNOWN Primary Pulmonary Hypertension Study Group
Mar 1, 1997·American Journal of Respiratory and Critical Care Medicine·E P Trulock
Mar 3, 1998·International Journal of Cardiology·J Somerville
Jan 14, 1999·European Heart Journal·L DalientoS Stone
Feb 9, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Susan C CharmanJohn Wallwork
Mar 19, 2002·American Journal of Respiratory and Critical Care Medicine·Gerald SimonneauUNKNOWN Treprostinil Study Group
Mar 22, 2002·The New England Journal of Medicine·Lewis J RubinGerald Simonneau
May 3, 2002·Journal of the American College of Cardiology·Nazzareno GalièUNKNOWN Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group
Jul 9, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Thomas K WaddellShaf H Keshavjee
Mar 5, 2003·The American Journal of Cardiology·Susan M FernandesMichael J Landzberg
Dec 10, 2003·Journal of the American College of Cardiology·Candice K SilversidesJudith Therrien
Jun 15, 2004·Journal of the American College of Cardiology·Gerald SimonneauAlfred Fishman
Jul 14, 2004·Chest·Vallerie V McLaughlinUNKNOWN American College of Chest Physicians
Sep 11, 2004·The European Respiratory Journal·K E RobertsJ H Morse
Apr 9, 2005·Pediatric Research·Maurice BeghettiJeffrey R Fineman
Sep 17, 2005·Cardiology in the Young·Rosangela de P S SoaresAntonio Augusto Lopes
Nov 3, 2005·Nature Clinical Practice. Cardiovascular Medicine·Marc R de Leval
Nov 18, 2005·The New England Journal of Medicine·Nazzareno GalièUNKNOWN Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group
Jun 28, 2006·Circulation·Nazzareno GalièUNKNOWN Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators
Oct 10, 2006·International Journal of Cardiology·Zek S LimGruschen R Veldtman
Feb 28, 2007·Circulation·Gerhard-Paul Diller, Michael A Gatzoulis

❮ Previous
Next ❯

Citations

May 30, 2009·Cardiology in the Young·Rolf M F Berger
Sep 17, 2013·Seminars in Respiratory and Critical Care Medicine·Shinichi Takatsuki, David Dunbar Ivy
Oct 12, 2013·Paediatric Drugs·Erika E Vorhies, David Dunbar Ivy
May 28, 2014·Microvascular Research·Alessio RungatscherGiuseppe Faggian
Dec 4, 2014·International Journal of Cardiology·Pamela MoceriKonstantinos Dimopoulos
Nov 28, 2013·Heart Failure Clinics·Alexander R OpotowskyMaurice Beghetti
Jan 18, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Diederik E van der FeenRolf M F Berger
Jul 4, 2012·Heart Failure Clinics·Vedant GuptaRichard A Krasuski
Jun 16, 2009·The Journal of Pediatrics·Rosa Laura E van LoonRolf M F Berger
Jun 17, 2011·Clinical Cardiology·Wei-Jie ZengUNKNOWN Sildenafil Therapy on Pulmonary Arterial Hypertension Associated With Different Types of Congenital Heart Disease Study Grou
Jan 25, 2017·Heart·Willemijn Mh ZijlstraRolf Mf Berger
Sep 30, 2016·Pulmonary Circulation·Willemijn M H ZijlstraRolf M F Berger
Nov 5, 2015·Circulation·Steven H AbmanUNKNOWN American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Clinical C
Jan 17, 2008·Cardiology in the Young·Ingram Schulze-Neick, Maurice Beghetti
Apr 30, 2013·American Journal of Physiology. Lung Cellular and Molecular Physiology·Michael G DickinsonRolf M F Berger
Nov 6, 2009·Molecular Systems Biology·Siebe B van AlbadaPieter Rein ten Wolde
Nov 30, 2019·Current Cardiology Reports·Jordan E Ezekian, Kevin D Hill
Jan 22, 2020·Paediatric Drugs·Catherine M AvitabileDavid Dunbar Ivy
Apr 22, 2020·Pulmonary Circulation·Balaji ArvindShyam S Kothari
Dec 22, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Mirjam E van AlbadaRolf M F Berger
Apr 16, 2021·Expert Review of Cardiovascular Therapy·Ana Barradas-PiresKonstantinos Dimopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Related Papers

Nederlands tijdschrift voor geneeskunde
J W Roos-HesselinkS E Spitaels
Circulation
Nazzareno GalieBosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators
Journal of the American College of Cardiology
Gérald SimonneauAlfred Fishman
© 2021 Meta ULC. All rights reserved